Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 47% ± 16% | |
brain | 17 studies | 31% ± 14% | |
peripheral blood | 16 studies | 25% ± 9% | |
intestine | 10 studies | 28% ± 14% | |
eye | 9 studies | 38% ± 16% | |
liver | 8 studies | 37% ± 20% | |
kidney | 7 studies | 28% ± 8% | |
uterus | 6 studies | 39% ± 11% | |
prostate | 5 studies | 36% ± 14% | |
skin | 5 studies | 23% ± 8% | |
breast | 5 studies | 32% ± 9% | |
bone marrow | 4 studies | 25% ± 6% | |
esophagus | 4 studies | 35% ± 13% | |
placenta | 3 studies | 32% ± 7% | |
ovary | 3 studies | 38% ± 10% | |
heart | 3 studies | 16% ± 1% | |
adipose | 3 studies | 34% ± 10% | |
pancreas | 3 studies | 31% ± 12% | |
thymus | 3 studies | 47% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 98% | 158389.79 | 451 / 459 | 100% | 374.25 | 1116 / 1118 |
thymus | 99% | 63314.94 | 648 / 653 | 99% | 187.28 | 597 / 605 |
brain | 96% | 100124.20 | 2549 / 2642 | 100% | 518.00 | 705 / 705 |
ovary | 99% | 109099.99 | 179 / 180 | 96% | 95.92 | 414 / 430 |
lung | 99% | 84939.58 | 573 / 578 | 96% | 200.20 | 1110 / 1155 |
bladder | 95% | 60613.57 | 20 / 21 | 91% | 118.91 | 459 / 504 |
stomach | 99% | 134768.24 | 354 / 359 | 84% | 81.12 | 240 / 286 |
esophagus | 87% | 78822.05 | 1258 / 1445 | 88% | 129.37 | 161 / 183 |
uterus | 78% | 31034.62 | 133 / 170 | 96% | 179.13 | 441 / 459 |
intestine | 78% | 40961.50 | 751 / 966 | 87% | 88.32 | 459 / 527 |
prostate | 71% | 26976.49 | 174 / 245 | 93% | 95.25 | 469 / 502 |
skin | 81% | 53606.23 | 1468 / 1809 | 82% | 99.22 | 389 / 472 |
pancreas | 65% | 22100.62 | 213 / 328 | 97% | 144.15 | 173 / 178 |
liver | 36% | 10495.43 | 81 / 226 | 93% | 710.77 | 379 / 406 |
kidney | 22% | 8509.46 | 20 / 89 | 82% | 95.66 | 742 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 49.97 | 1 / 1 |
adipose | 99% | 196260.20 | 1187 / 1204 | 0% | 0 | 0 / 0 |
spleen | 95% | 59232.42 | 229 / 241 | 0% | 0 | 0 / 0 |
muscle | 95% | 231318.60 | 760 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 276.57 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 83% | 145.36 | 24 / 29 |
blood vessel | 79% | 57346.83 | 1056 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 75% | 60564.33 | 697 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 54.74 | 56 / 80 |
adrenal gland | 36% | 11608.30 | 93 / 258 | 21% | 17.09 | 48 / 230 |
heart | 51% | 16998.59 | 435 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_0008283 | Biological process | cell population proliferation |
GO_0042254 | Biological process | ribosome biogenesis |
GO_0009749 | Biological process | response to glucose |
GO_0010594 | Biological process | regulation of endothelial cell migration |
GO_1903670 | Biological process | regulation of sprouting angiogenesis |
GO_0009267 | Biological process | cellular response to starvation |
GO_1904749 | Biological process | regulation of protein localization to nucleolus |
GO_0006538 | Biological process | glutamate catabolic process |
GO_0006542 | Biological process | glutamine biosynthetic process |
GO_0018345 | Biological process | protein palmitoylation |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0044297 | Cellular component | cell body |
GO_0097386 | Cellular component | glial cell projection |
GO_0005634 | Cellular component | nucleus |
GO_0004356 | Molecular function | glutamine synthetase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0019706 | Molecular function | protein-cysteine S-palmitoyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GLUL |
Protein name | Glutamine synthetase (EC 6.3.1.2) Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225) |
Synonyms | hCG_24393 GLNS PIG59 |
Description | FUNCTION: Glutamine synthetase that catalyzes the ATP-dependent conversion of glutamate and ammonia to glutamine . Its role depends on tissue localization: in the brain, it regulates the levels of toxic ammonia and converts neurotoxic glutamate to harmless glutamine, whereas in the liver, it is one of the enzymes responsible for the removal of ammonia (By similarity). Essential for proliferation of fetal skin fibroblasts . Independently of its glutamine synthetase activity, required for endothelial cell migration during vascular development: acts by regulating membrane localization and activation of the GTPase RHOJ, possibly by promoting RHOJ palmitoylation . May act as a palmitoyltransferase for RHOJ: able to autopalmitoylate and then transfer the palmitoyl group to RHOJ . Plays a role in ribosomal 40S subunit biogenesis . . |
Accessions | A0A2R8YDT1 ENST00000339526.8 ENST00000642379.1 A8YXX4 ENST00000311223.9 ENST00000417584.6 A1L199 P15104 ENST00000331872.11 |